Filmocid Process Matin
Food supplement declared in France
Filmocid Process Matin is a food supplement declared in France. Status: retiré du marché le 21 October 2026. 1 rule of use applies to its ingredients (limits and warnings).
- Brand
- not provided
- Food business operator placing the product on the market
- LAB. O2&VIE SAS
- Status
- Retiré du marché le 21 October 2026
- Form
- Gélule
- Daily dose
- Prendre 2 gélules par jour
- Not recommended for (according to the manufacturer)
- Adolescents (moins de 18 ans), Femmes allaitantes, Femmes enceintes, Sous anticoagulants, Sous antidiabétiques, Utilisation prolongée
Declaration 375753, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.
Regulatory points
- Conditions légales
Andrographis paniculata (Burm. f.) Nees: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux femmes enceintes.
Source: French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, arrêté du 24 juin 2014, annexe I.
- Information
Retiré du marché le 21 October 2026, according to Compl'Alim.
Source: Compl'Alim, food supplement declarations (France).
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Andrographis paniculata (Burm. f.) Nees | Parties aériennes | Extrait sec hydroalcoolique | 300 mg |
| Styphnolobium japonicum (L.) Schott | Feuille | Extrait sec hydroalcoolique | 107 mg |
| Reynoutria japonica Houtt. | Racine | Extrait sec hydroalcoolique | 31 mg |
Additives
E464
Other ingredients
amidon de riz
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Label warnings
Ne pas utiliser en cas de grossesse. Déconseillé aux femmes allaitantes et aux enfants. Pour les personnes sous traitement antidiabétique ou anticoagulant, ne pas consommer le produit sans avoir pris l'avis au préalable d'un professionnel de santé. L'usage prolongé est déconseillé.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Other declarations with the same name
In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.
- Filmocid process matin LAB. O2&VIE SAS, declared in 2025 : different composition: 1 ingredient(s) added, 1 missing